Amgen (NASDAQ:AMGN) has started a bond offering with the proceeds being used to help fund its planned $28B acquisition of Horizon Therapeutics (HZNP).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,